Imaging of COVID-19 Patients to assess predisposing factors causing mucormycosis
Keywords:
COVID-19, paranasal sinuses, ROM (Rhino orbital mucormycosis)Abstract
Introduction: With the second wave of Covid 19, the incidence of mucormycosis has seen an upsurge in patients recovered from Covid 19 infection. Aims & Objectives: The present study aims to describe the various symptoms reported by the patients and to describe the various CT findings in the patients suffering from Mucormycosis. Materials and methods: This prospective study was done on 21 post Covid cases from May 2021 to July 2021 at Department of Radiology, VMKV Medical College & Hospitals. Patients who have presented with chest complaints and symptoms of sinusitis such as facial pain, headache, nasalblock, orbital swelling and pain were subjected to CT-Chest, CT-PNS. Imaging findings were correlated with clinical history and findings. Results: Radiological findings showed involvement of ethmoid 19/21(90.78 %) maxillary 17/21 (80.95 %) sinus, followed by sphenoid13/21 (61.90%) and frontal 6/21(28.57 %).Out of 2 patients studied, 15 patients (71.43%) had type 2 diabetes mellitus, 5(23.81%) patients had chronic renal failure, 5(23.81%) patients developed acute renal failure and 2(9.52%) patients received immunosuppressive therapy due to myelodysplastic syndrome. Conclusion: Early diagnosis, control of predisposing factors prompt initiation of antifungal therapy and radical debridement of involved sinuses are very essential for improving outcomes.
Downloads
References
M. Maes, E. Higginson, J. Pereira-Dias, M.D. Curran, S. Parmar, F. Khokhar, D. Cuchet-Lourenço, J. Lux, S. Sharma-Hajela, B. Ravenhill, I. Hamed, L. Heales, R. Mahroof, A. Soderholm, S. Forrest, S. Sridhar, N.M. Brown, S. Baker, V. Navapurkar, G. Dougan, J. Bartholdson Scott, A. Conway Morris, Ventilator- associated pneumonia in critically ill patients with COVID-19, Crit. Care. 25 (2021) 25.
J.-P. Gangneux, M.-E. Bougnoux, E. Dannaoui, M. Cornet, J.R. Zahar, Invasive fungal diseases during COVID-19: we should be prepared, J. Mycol. Med. 30 (2020), 100971.
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL et al (2005) Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41:634–653 2.
Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP (2012) Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54 (Suppl 1):S23–S34
Anson Jose, Shagun Singh, Ajoy Roychoudhury, Yathin Kholakiya, Saurabh Arya, Sunanda Roychoudhury, Current Understanding in the Pathophysiology of SARS-CoV-2Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review.J. Maxillofac. Oral Surg. 2021;20(3):373–380.
Sharma S, Grover M, Bhargava S, Samdani S, Kataria T . Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J LaryngolOtol, 2021;1–6
N.C. Sharma, India reports 40,854 cases of black fungus so far, MINT. 2021
M. Sen, S. Lahane, T.P. Lahane, R. Parekh, S.G. Honavar, Mucor in a viral land: a tale of two pathogens, Indian J. Ophthalmol. 2021;69 : 244–252.
Nurettin Bayram ·Cemal Ozsaygılı · Hafize Sav · Yucel Tekin · Medine Gundogan · Emine Pangal · Ayse Cicek · İbrahim Özcan. Susceptibility of severe COVID 19 patients to rhino orbital mucormycosis fungal infection in different clinical manifestations. Japanese Journal of Ophthalmology, 2021
Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4):102146. doi:10.1016/j.dsx.2021.05.019
Bhansali A, Bhadada S, Sharma A, Suresh V, Gupta A, Singh P, et al. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J. 2004;80:670–4.
Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. SurvOphthalmol. 1994;39:3–22.
Al-Tawfiq JA, Alhumaid S, Alshukairi AN, et al. COVID-19 and mucormycosis superinfection: the perfect storm. Infection. 2021;49(5):833-853. doi:10.1007/s15010-021-01670-1
Gupta S, Goyal R, Kaore NM. Rhino-orbital-cerebral mucormycosis: battle with the deadly enemy. Indian J Otolaryngol Head Neck Surg. 2020;72:104–11.
Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020; 12: e10726. 14. Mekonnen ZK, Ashraf DC, Jankowski T, Grob SR, Vagefi MR, Kersten RC, et al. Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome. Ophthalmic PlastReconstr Surg. 2021; 37: e40–80.
Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. 2021;42:264.e5-264.e8.
Khidoyatova, M. R., Kayumov, U. K., Inoyatova, F. K., Fozilov, K. G., Khamidullaeva, G. A., & Eshpulatov, A. S. (2022). Clinical status of patients with coronary artery disease post COVID-19. International Journal of Health & Medical Sciences, 5(1), 137-144. https://doi.org/10.21744/ijhms.v5n1.1858
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
